News & Perspective

Feb 08, 2019

Feb 08, 2019

Stewardship / Resistance Scan for Feb 08, 2019

Inadequate TB drug-susceptibility testing
New UK guidance on antibiotics for acute cough

Aug 31, 2018

Aug 31, 2018

ASP Scan (Weekly) for Aug 31, 2018

C diff testing in the NICU
Resistant gonorrhea in Europe
ESBL bacteria in sprouts
Antibiotic resistance risk factors
Business case for stewardship
UK FMT C diff guidelines
Pharmacist-led stewardship
Typhoid vaccine as stewardship tool
Web training for antibiotic stewardship
Chest x-ray and pneumonia
New antibiotic for intra-abdominal infections
Bedaquiline for MDR-TB
Australian stewardship study

Sep 08, 2017

Sep 08, 2017

ASP Scan (Weekly) for Sep 08, 2017

ESBL-E in pregnant women
Antimicrobial resistance in Southeast Asia
Precision antimicrobials
Money for antibiotic development
Canada AMR framework
Pharmacist stewardship
CRE treatment

May 18, 2011

May 18, 2011

Experts: Regulatory issues are main reason for keeping smallpox virus

(CIDRAP News) – When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»